Stroman David W. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Dec 10, 2012
Insider Transaction Report
Form 4
Stroman David W.
SVP, Ophthalmic Product Devt.
Transactions
- Purchase
Common Stock
2012-12-06$1.24/sh+10,000$12,400→ 22,000 total - Purchase
Warrants to purchase Common Stock
2012-12-06$0.01/sh+7,500$75→ 7,500 totalExercise: $1.50From: 2012-12-11Exp: 2013-12-11→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]At the public offering of the Company on December 6, 2012, Dr. Stroman purchased 10,000 shares of common stock with 7,500 warrants to purchase common stock.
- [F2]At the public offering of the Company on December 6, 2012, Dr. Stroman purchased 10,000 shares of common stock with 7,500 warrants to purchase common stock.